<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38932398</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>17</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Prior COVID-19 Diagnosis, Severe Outcomes, and Long COVID among U.S. Adults, 2022.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">669</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12060669</ELocationID><Abstract><AbstractText>Given the increase in COVID-19 emergency department visits and hospitalizations during the winter of 2023-2024, identifying groups that have a high prevalence of COVID-19 cases, severity, and long-term symptoms can help increase efforts toward reducing disparities and prevent severe COVID-19 outcomes. Using data from the 2022 National Health Interview Survey (<i>n</i> = 27,651), we assessed the prevalence of COVID-19 outcomes (prior diagnosis, moderate/severe COVID-19, and long COVID) by sociodemographic characteristics and factors associated with each COVID-19 outcome. Approximately one third of adults reported a prior COVID-19 diagnosis (30.7%), while one half (51.6%) who had COVID-19 reported moderate or severe symptoms, and one fifth (19.7%) who had COVID-19 symptoms reported long COVID. The following were associated with higher odds of moderate/severe COVID-19 and long COVID: havinga high-risk condition (aOR = 1.20, OR = 1.52); having anxiety or depression (OR = 1.46, OR = 1.49); having a disability (OR = 1.41, OR = 1.60); and having a food insecurity (OR = 1.37, OR = 1.50) compared to a lack of these conditions. Having two or more COVID-19 vaccinations was associated with lower odds of a COVID-19 diagnosis (OR = 0.75), moderate/severe COVID-19 (OR = 0.86), and long COVID (OR = 0.82). Improving vaccination coverage and reducing disparities in COVID-19 outcomes could advance health equities and protect against future resurgence of disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Kimberly H</ForeName><Initials>KH</Initials><Identifier Source="ORCID">0000-0002-3558-6983</Identifier><AffiliationInfo><Affiliation>Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Yingjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Public Health &amp; Community Medicine, Tufts University School of Medicine, Boston, MA 02111, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Siyu</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0717-5343</Identifier><AffiliationInfo><Affiliation>Department of Public Health &amp; Community Medicine, Tufts University School of Medicine, Boston, MA 02111, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bednarczyk</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emory Vaccine Center, Emory University, Atlanta, GA 30317, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasudevan</LastName><ForeName>Lavanya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corlin</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3348-9063</Identifier><AffiliationInfo><Affiliation>Department of Public Health &amp; Community Medicine, Tufts University School of Medicine, Boston, MA 02111, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Civil and Environmental Engineering, Tufts University School of Engineering, Medford, MA 02155, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R37 CA234119</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 outcomes</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">disparities</Keyword><Keyword MajorTopicYN="N">doctor diagnosis</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">severe COVID-19</Keyword><Keyword MajorTopicYN="N">vaccine confidence</Keyword><Keyword MajorTopicYN="N">vaccine hesitancy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38932398</ArticleId><ArticleId IdType="pmc">PMC11209607</ArticleId><ArticleId IdType="doi">10.3390/vaccines12060669</ArticleId><ArticleId IdType="pii">vaccines12060669</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  Statement on the Fifteenth Meeting of the IHR (2005) Emergency Committee on the COVID-19 Pandemic.  [(accessed on 14 January 2024)];2023  Available online:  https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic?adgroupsurvey={adgroupsurvey}&amp;gclid=Cj0KCQjw8NilBhDOARIsAHzpbLBFHQNmP7_R2UD4_KXEmDslaE7EzLlsb6SMnkJIfIRYRRlQ-T83lBgaAiVNEALw_wcB.</Citation></Reference><Reference><Citation>United Nations  WHO Chief Declares End to COVID-19 as a Global Health Emergency.  [(accessed on 16 January 2024)];2023  Available online:  https://news.un.org/en/story/2023/05/1136367.</Citation></Reference><Reference><Citation>CDC  COVID Data Tracker.  [(accessed on 21 February 2024)];2023  Available online:  https://covid.cdc.gov/covid-data-tracker/#datatracker-home.</Citation></Reference><Reference><Citation>Gao Y.D., Ding M., Dong X., Zhang J.J., Kursat Azkur A., Azkur D., Gan H., Sun Y.L., Fu W., Li W., et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76:428&#x2013;455. doi: 10.1111/all.14657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth A., Reed A.B., Ponzo S., Yassaee A., Aral M., Plans D., Labrique A., Mohan D. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PLoS ONE. 2021;16:e0247461. doi: 10.1371/journal.pone.0247461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247461</ArticleId><ArticleId IdType="pmc">PMC7932512</ArticleId><ArticleId IdType="pubmed">33661992</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen W., Gulati G., Kelly B.D. Mental health in the COVID-19 pandemic. QJM. 2020;113:311&#x2013;312. doi: 10.1093/qjmed/hcaa110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa110</ArticleId><ArticleId IdType="pmc">PMC7184387</ArticleId><ArticleId IdType="pubmed">32227218</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkumar R.P. COVID-19 and mental health: A review of the existing literature. Asian J. Psychiatr. 2020;52:102066. doi: 10.1016/j.ajp.2020.102066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2020.102066</ArticleId><ArticleId IdType="pmc">PMC7151415</ArticleId><ArticleId IdType="pubmed">32302935</ArticleId></ArticleIdList></Reference><Reference><Citation>Usher K., Durkin J., Bhullar N. The COVID-19 pandemic and mental health impacts. Int. J. Ment. Health Nurs. 2020;29:315&#x2013;318. doi: 10.1111/inm.12726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/inm.12726</ArticleId><ArticleId IdType="pmc">PMC7262128</ArticleId><ArticleId IdType="pubmed">32277578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfson J.A., Leung C.W. Food Insecurity during COVID-19: An Acute Crisis with Long-Term Health Implications. Am. J. Public. Health. 2020;110:1763&#x2013;1765. doi: 10.2105/AJPH.2020.305953.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2020.305953</ArticleId><ArticleId IdType="pmc">PMC7662000</ArticleId><ArticleId IdType="pubmed">32970451</ArticleId></ArticleIdList></Reference><Reference><Citation>Niles M.T., Bertmann F., Belarmino E.H., Wentworth T., Biehl E., Neff R. The Early Food Insecurity Impacts of COVID-19. Nutrients. 2020;12:2096. doi: 10.3390/nu12072096.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12072096</ArticleId><ArticleId IdType="pmc">PMC7400862</ArticleId><ArticleId IdType="pubmed">32679788</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  People with Certain Medical Conditions.  [(accessed on 14 January 2024)];2022  Available online:  https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.</Citation></Reference><Reference><Citation>Nguyen K.H., Chen S., Morris K., Chui K., Allen J.D. Mental health symptoms and association with COVID-19 vaccination receipt and intention to vaccinate among adults, United States. Prev. Med. 2022;154:106905. doi: 10.1016/j.ypmed.2021.106905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2021.106905</ArticleId><ArticleId IdType="pmc">PMC8634733</ArticleId><ArticleId IdType="pubmed">34863815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryerson A.B., Rice C.E., Hung M.C., Patel S.A., Weeks J.D., Kriss J.L., Peacock G., Lu P.J., Asif A.F., Jackson H.L., et al. Disparities in COVID-19 Vaccination Status, Intent, and Perceived Access for Noninstitutionalized Adults, by Disability Status-National Immunization Survey Adult COVID Module, United States, May 30&#x2013;June 26, 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1365&#x2013;1371. doi: 10.15585/mmwr.mm7039a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7039a2</ArticleId><ArticleId IdType="pmc">PMC8486390</ArticleId><ArticleId IdType="pubmed">34591826</ArticleId></ArticleIdList></Reference><Reference><Citation>Testa A., Sharma B.B. Food Insecurity and COVID-19 Vaccination Status and Vaccination Hesitancy in the United States. Fam. Community Health. 2023;46:136&#x2013;142. doi: 10.1097/FCH.0000000000000357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FCH.0000000000000357</ArticleId><ArticleId IdType="pmc">PMC9930687</ArticleId><ArticleId IdType="pubmed">36799947</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen K.H., Irvine S., Epstein R., Allen J.D., Corlin L. Prior COVID-19 Infection, Mental Health, Food and Financial Insecurity, and Association with COVID-19 Vaccination Coverage and Intent among College-Aged Young Adults, US, 2021. Prev. Chronic. Dis. 2021;18:E101. doi: 10.5888/pcd18.210260.</Citation><ArticleIdList><ArticleId IdType="doi">10.5888/pcd18.210260</ArticleId><ArticleId IdType="pmc">PMC8718122</ArticleId><ArticleId IdType="pubmed">34914579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimani M.E., Sarr M., Cuffee Y., Liu C., Webster N.S. Associations of Race/Ethnicity and Food Insecurity with COVID-19 Infection Rates across US Counties. JAMA Netw. Open. 2021;4:e2112852. doi: 10.1001/jamanetworkopen.2021.12852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12852</ArticleId><ArticleId IdType="pmc">PMC8188266</ArticleId><ArticleId IdType="pubmed">34100936</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Xu R., Volkow N.D. Increased risk of COVID-19 infection and mortality in people with mental disorders: Analysis from electronic health records in the United States. World Psychiatry. 2021;20:124&#x2013;130. doi: 10.1002/wps.20806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20806</ArticleId><ArticleId IdType="pmc">PMC7675495</ArticleId><ArticleId IdType="pubmed">33026219</ArticleId></ArticleIdList></Reference><Reference><Citation>NCHS  National Health Interview Survey 2022 Survey Description.  [(accessed on 13 December 2023)];2022  Available online:  https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2022/srvydesc-508.pdf.</Citation></Reference><Reference><Citation>NIH  Clinical Spectrum of SARS-CoV-2 Infection.  [(accessed on 8 November 2023)];2023  Available online:  https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/</Citation></Reference><Reference><Citation>Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., Iskander J.K., Wortley P.M., Shay D.K., Bresee J.S., et al. Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm. Rep. 2010;59:1&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">20689501</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Functioning and Disability.  [(accessed on 25 January 2024)];2022  Available online:  https://www.cdc.gov/nchs/covid19/pulse/functioning-and-disability.htm.</Citation></Reference><Reference><Citation>Kleinbaum D.G., Kupper L.L., Muller K.E., Nizam A. Applied Regression Analysis and Other Multivariable Methods. Duxbury Press; Belmont, CA, USA: 1988.</Citation></Reference><Reference><Citation>Feikin D.R., Higdon M.M., Abu-Raddad L.J., Andrews N., Araos R., Goldberg Y., Groome M.J., Huppert A., O&#x2019;Brien K.L., Smith P.G., et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: Results of a systematic review and meta-regression. Lancet. 2022;399:924&#x2013;944. doi: 10.1016/S0140-6736(22)00152-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00152-0</ArticleId><ArticleId IdType="pmc">PMC8863502</ArticleId><ArticleId IdType="pubmed">35202601</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed I., Nauman A., Paul P., Ganesan S., Chen K.H., Jalil S.M.S., Jaouni S.H., Kawas H., Khan W.A., Vattoth A.L., et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: A systematic review. Hum. Vaccin. Immunother. 2022;18:2027160. doi: 10.1080/21645515.2022.2027160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2027160</ArticleId><ArticleId IdType="pmc">PMC8862168</ArticleId><ArticleId IdType="pubmed">35113777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P., Ssentongo A.E., Voleti N., Groff D., Sun A., Ba D.M., Nunez J., Parent L.J., Chinchilli V.M., Paules C.I. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: A systematic review and meta-analysis. BMC Infect. Dis. 2022;22:439. doi: 10.1186/s12879-022-07418-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07418-y</ArticleId><ArticleId IdType="pmc">PMC9077344</ArticleId><ArticleId IdType="pubmed">35525973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Duan Y., Qian J., Qu Y., Wang Y., Fan G., Huang Q., Li Z., Yang W., Feng L. A Large-Scale Online Survey on Clinical Severity and Associated Risk Factors for SARS-CoV-2 Omicron Infection-China, April&#x2013;May 2023. China CDC Wkly. 2024;6:305&#x2013;311. doi: 10.46234/ccdcw2024.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2024.059</ArticleId><ArticleId IdType="pmc">PMC11082054</ArticleId><ArticleId IdType="pubmed">38736994</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein E.Y., Fall A., Norton J.M., Eldesouki R.E., Abdullah O., Han L., Yunker M., Mostafa H.H. Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis. J. Clin. Virol. 2023;165:105500. doi: 10.1016/j.jcv.2023.105500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2023.105500</ArticleId><ArticleId IdType="pmc">PMC10232717</ArticleId><ArticleId IdType="pubmed">37290254</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC COVID-19 Response Team Severe outcomes among patients with coronavirus disease 2019 (COVID-19)&#x2014;United States, February 12&#x2013;March 16, 2020. Morb. Mortal. Wkly. Rep. 2020;69:343&#x2013;346. doi: 10.15585/mmwr.mm6912e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6912e2</ArticleId><ArticleId IdType="pmc">PMC7725513</ArticleId><ArticleId IdType="pubmed">32214079</ArticleId></ArticleIdList></Reference><Reference><Citation>Christie A., Henley S.J., Mattocks L., Fernando R., Lansky A., Ahmad F.B., Adjemian J., Anderson R.N., Binder A.M., Carey K., et al. Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths among Older Adults Following the Introduction of COVID-19 Vaccine-United States, September 6, 2020&#x2013;May 1, 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:858&#x2013;864. doi: 10.15585/mmwr.mm7023e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7023e2</ArticleId><ArticleId IdType="pmc">PMC8191865</ArticleId><ArticleId IdType="pubmed">34111059</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  End of the Federal COVID-19 Public Health Emergency (PHE) Declaration.  [(accessed on 1 February 2024)];2023  Available online:  https://www.cdc.gov/coronavirus/2019-ncov/your-health/end-of-phe.html.</Citation></Reference><Reference><Citation>Feikin D.R., Abu-Raddad L.J., Andrews N., Davies M.A., Higdon M.M., Orenstein W.A., Patel M.K. Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization. Vaccine. 2022;40:3516&#x2013;3527. doi: 10.1016/j.vaccine.2022.04.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.04.069</ArticleId><ArticleId IdType="pmc">PMC9058052</ArticleId><ArticleId IdType="pubmed">35595662</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Self W.H., Gaglani M., Ginde A.A., Douin D.J., Talbot H.K., Casey J.D., Mohr N.M., Zepeski A., McNeal T., et al. Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death-United States, March 2021&#x2013;January 2022. MMWR Morb. Mortal. Wkly. Rep. 2022;71:459&#x2013;465. doi: 10.15585/mmwr.mm7112e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7112e1</ArticleId><ArticleId IdType="pmc">PMC8956334</ArticleId><ArticleId IdType="pubmed">35324878</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajema K.L., Dahl R.M., Prill M.M., Meites E., Rodriguez-Barradas M.C., Marconi V.C., Beenhouwer D.O., Brown S.T., Holodniy M., Lucero-Obusan C., et al. Effectiveness of COVID-19 mRNA Vaccines against COVID-19-Associated Hospitalization-Five Veterans Affairs Medical Centers, United States, February 1&#x2013;August 6, 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1294&#x2013;1299. doi: 10.15585/mmwr.mm7037e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7037e3</ArticleId><ArticleId IdType="pmc">PMC8445376</ArticleId><ArticleId IdType="pubmed">34529636</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferdinands J.M., Rao S., Dixon B.E., Mitchell P.K., DeSilva M.B., Irving S.A., Lewis N., Natarajan K., Stenehjem E., Grannis S.J., et al. Waning of vaccine effectiveness against moderate and severe COVID-19 among adults in the US from the VISION network: Test negative, case-control study. BMJ. 2022;379:e072141. doi: 10.1136/bmj-2022-072141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072141</ArticleId><ArticleId IdType="pmc">PMC9527398</ArticleId><ArticleId IdType="pubmed">36191948</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemaitelly H., Abu-Raddad L.J. Waning effectiveness of COVID-19 vaccines. Lancet. 2022;399:771&#x2013;773. doi: 10.1016/S0140-6736(22)00277-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00277-X</ArticleId><ArticleId IdType="pmc">PMC8871492</ArticleId><ArticleId IdType="pubmed">35219385</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  COVID-19 ACIP Vaccine Recommendations.  [(accessed on 3 January 2024)];2022  Available online:  https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html.</Citation></Reference><Reference><Citation>CDC  COVID-19 Vaccine Recommendations for Children and Teens.  [(accessed on 28 February 2024)];2022  Available online:  https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccines-children-teens.html#:~:text=CDC%20recommends%20everyone%20ages%206,%2D19%20booster%2C%20if%20eligible.</Citation></Reference><Reference><Citation>CDC  COVID-19 Vaccinations in the United States.  [(accessed on 13 November 2023)];2022  Available online:  https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total.</Citation></Reference><Reference><Citation>CDC  12 COVID-19 Vaccination Strategies for Your Community.  [(accessed on 25 January 2024)];2022  Available online:  https://www.cdc.gov/vaccines/covid-19/vaccinate-with-confidence/community.html.</Citation></Reference><Reference><Citation>Nguyen C.T.T., Sandhi A., Lee G.T., Nguyen L.T.K., Kuo S.Y. Prevalence of and factors associated with postnatal depression and anxiety among parents of preterm infants: A systematic review and meta-analysis. J. Affect. Disord. 2023;322:235&#x2013;248. doi: 10.1016/j.jad.2022.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.11.015</ArticleId><ArticleId IdType="pubmed">36400151</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchflower D.G., Bryson A. Long COVID in the United States. PLoS ONE. 2023;18:e0292672. doi: 10.1371/journal.pone.0292672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0292672</ArticleId><ArticleId IdType="pmc">PMC10621843</ArticleId><ArticleId IdType="pubmed">37917610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford N.D., Slaughter D., Edwards D., Dalton A., Perrine C., Vahratian A., Saydah S. Long COVID and Significant Activity Limitation among Adults, by Age-United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb. Mortal. Wkly. Rep. 2023;72:866&#x2013;870. doi: 10.15585/mmwr.mm7232a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford N.D., Agedew A., Dalton A.F., Singleton J., Perrine C.G., Saydah S. Notes from the Field: Long COVID Prevalence Among Adults-United States, 2022. MMWR Morb. Mortal. Wkly. Rep. 2024;73:135&#x2013;136. doi: 10.15585/mmwr.mm7306a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7306a4</ArticleId><ArticleId IdType="pmc">PMC10899083</ArticleId><ArticleId IdType="pubmed">38359012</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>